# Levemir-Body Composition and Energy Metabolism

> **NCT00862875** · PHASE4 · COMPLETED · sponsor: **Institut de Recherches Cliniques de Montreal** · enrollment: 42 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Detemir or Glargine

## Key facts

- **NCT ID:** NCT00862875
- **Lead sponsor:** Institut de Recherches Cliniques de Montreal
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2014-04
- **Final completion:** —
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-05-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862875, "Levemir-Body Composition and Energy Metabolism". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00862875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*